| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.0006 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0008 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0009 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |